That is very interesting if he is referring to BoM because it is double blind.

Perhaps he is referring to the futility analysis. As I understand it the FA is focused on safety and efficacy. Passing the FA suggests there is enough efficacy at that stage to suggest that the trial has enough of a positive probability of achieving the end target goals (in this case 3 point MACE).

If that is a correct interpretation then the FA is a big deal IMHO. However, as has been pointed out in past posts many trials fail after their FA.

Curious to hear what others feel Dr Wong was referring to.

This is a very interesting and telling time. If the new financing is just an extension and addition to the LOC then we know that KD is still happy putting up an almost infinitely small % of his billions for this bet. If on the other hand it is a new geographic partner with downstream capabilities it suggests a big vote of confidence in the science and market potential. If it is a deal with a development partner it is another vote of confidence in the science.

Oh well, we'll see soon. I don't see any option for Don to finance through a float on the stock market. The share price is far too low.

Cheers

Toinv